Caredx, inc. (CDNA)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Total revenue

127,068

76,569

48,324

40,631

28,144

27,306

22,098

20,451

Cost of revenue

45,455

32,987

21,371

10,882

10,273

8,541

9,078

7,930

Gross profit

81,613

43,582

26,953

-

-

-

-

-

Operating expenses:
Cost of product

-

-

-

-

0

0

-

-

Research and development

30,711

14,514

12,388

12,385

9,333

3,846

3,176

4,752

Sales and marketing

38,894

21,670

12,808

11,166

8,349

6,472

5,892

5,417

General and administrative

36,540

22,976

20,093

20,725

12,247

8,436

4,809

4,694

Goodwill impairment

0

0

1,958

13,021

0

0

-

-

Change in estimated fair value of contingent consideration

-

-

-

-456

-126

-1,239

0

0

Total operating expenses

106,145

59,160

47,247

77,963

40,076

26,056

22,955

22,793

Loss from operations

-24,532

-15,578

-20,294

-37,332

-11,932

1,250

-857

-2,342

Other income (expense):
Interest income, net

985

-3,701

-5,863

-1,860

-1,587

-2,116

-2,149

-2,703

Debt extinguishment expenses

0

5,780

459

0

-

-

-

-

Change in estimated fair value of common stock warrant liability

319

-22,978

-29,622

-250

0

225

-

-

Other expense, net

-719

-178

-1,031

-1,920

-188

-78

-536

-14

Total other expense

585

-32,637

-36,975

-

-

-

-

-

Loss before income taxes

-23,947

-48,215

-57,269

-41,362

-13,707

-719

-3,542

-5,059

Income tax benefit

-1,979

-1,434

-1,709

-1,606

0

-1,500

0

0

Net loss

-21,968

-46,781

-55,560

-39,756

-13,707

781

-

-

Net loss attributable to noncontrolling interest

0

-25

-91

-287

0

0

-

-

Net loss

-21,968

-46,756

-55,469

-39,469

-13,707

781

-3,542

-5,059

Net loss per share (Note 3):
Basic (in dollars per share)

-0.52

-1.31

-2.38

-2.39

-1.16

0.13

-3.50

-5.01

Diluted (in dollars per share)

-0.52

-1.31

-2.38

-2.39

-1.16

0.10

-3.50

-5.01

Weighted-average shares used to compute net loss per share:
Basic (in shares)

42,151

35,638

23,332

16,496

11,860

5,815

1,010

1,009

Diluted (in shares)

42,151

35,638

23,332

16,496

11,860

9,283

1,010

1,009

Testing services revenue
Total revenue

104,550

60,300

33,106

29,680

27,881

25,842

21,672

19,730

Product revenue
Total revenue

18,279

15,674

14,634

10,715

0

0

-

-

Digital and other revenue
Revenue

4,239

595

584

236

263

1,464

426

721

Product [Member]
Cost of testing services and product

-

-

-

10,240

-

-

-

-